Alan Mateo is of 10x Genomics, Inc.. Currently has a direct ownership of 77,048 shares of TXG, which is worth approximately $960,788. The most recent transaction as insider was on Jun 03, 2025, when has been sold 15,357 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77K
24.89% 3M change
n/a 12M change
Total Value Held $960,788

ALAN MATEO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2025
BUY
Grant, award, or other acquisition
-
15,357 Added 16.62%
77,048 Class A Common Stock
Feb 21 2025
BUY
Open market or private purchase
$445,600 $11.14 p/Share
40,000 Added 39.33%
61,691 Class A Common Stock
Jul 31 2024
BUY
Grant, award, or other acquisition
-
21,691 Added 50.0%
21,691 Class A Common Stock

Also insider at

VEEV
VEEVA SYSTEMS INC Healthcare
AM

Alan Mateo

Pleasanton, CA

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG